Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...
A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...
According to a letter (PDF) signed by US Senators Elizabeth Warren (D-Mass), Angela Alsobrooks (D-Md), Richard Blumenthal ...
Scribe Therapeutics has become the latest biotech to list on the Nasdaq in the US, raising more than $155 million to advance ...
Life sciences equipment and consumable manufacturer Repligen has reached a deal to buy cell therapy specialist BioLife ...
A woman from the Wirral in the UK has become the first patient in the world to receive an experimental cancer vaccine ...
A dual GLP-1 and glucagon agonist developed by Altimmune has been shown to reduce drinking in people with alcohol use ...
Hogan Lovells partner Alice Valder Curran returned to join pharmaphorum editor-in-chief Jonah Comstock to elucidate some of ...
After three knockbacks by the FDA, Outlook Therapeutics has finally pushed its therapy for wet age-related macular ...
AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss ...
Moreover, there are blood tests based on biomarkers that measure the body's immune response to infection, such as the Qiagen ...
Netherlands- and Belgium-based biotech argenx has agreed to buy US biotech Forte Biosciences for up to $2.2 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results